Chapter 33: Substance Use Disorders II: Alcohol

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Usually, when you prescribe a medication,

there's a specific target, like a lock for a key.

Right.

A specific receptor.

Exactly.

You give a beta blocker.

It blocks beta receptors.

It's a clean, predictable mechanism.

But then you look at alcohol.

Oh, yeah.

Alcohol is a whole different animal.

I mean, ethanol doesn't use a key.

It just kicks in the front door, rewires the entire house, and sets off the alarm system.

That is a perfect way to describe it.

It's the ultimate multi -system disruptor.

And suddenly, that clean, predictable pharmacological model is completely thrown out the window.

Which forces you to change your approach.

You have to.

You can't just memorize a list of side effects.

You really have to understand the underlying pathophysiology.

Right.

Like how ethanol actually flips those switches in the brain and the body.

That is the only way you can safely manage the fallout, particularly when a patient is trying to quit.

And that is exactly what we are getting into today on the Deep Dive.

Welcome to your personalized one -on -one clinical tutoring session.

Glad to be here.

Our mission today is to take you on a clinical reasoning journey through Chapter 33 of Lens

Pharmacotherapeutics.

We are mastering the pharmacology of alcohol and the clinical management of alcohol use disorder or AUD.

We're going to walk through this exactly how the text breaks it down.

Yep.

What ethanol does to the body, how the body tries to process it, and how you choose the right therapeutic interventions to keep your patients safe.

So let's start with the brain.

Always the best place to start.

Before we can figure out how to help a patient quit, we need to know what we're up against.

What is alcohol actually doing to neural pathways?

So the acute effects are primarily driven by alcohol's interaction with three specific target proteins that regulate neuronal excitability.

Okay.

What are the three?

We are looking at receptors for GABA, receptors for glutamate, and the 5 -HT3 subset of serotonin receptors.

Got it.

Let's break those down.

Well, GABA is your principal inhibitory neurotransmitter in the central nervous system.

When alcohol binds to a GABA receptor, it enhances that inhibition.

Meaning it causes widespread depression of CNS activity.

Exactly.

But it doesn't stop there.

At the exact same time, it's hitting glutamate.

And glutamate is your major excitatory transmitter.

Right.

Alcohol binds to those glutamate receptors and just blocks them.

So it's reducing overall CNS activity even further, but from a completely different angle.

Yeah, you have this dual action CNS depression.

It's a heavy effect.

But then there's the third target, which involves the 5 -HT3 receptor.

Those are located in the brain's reward circuit, right?

Yes, exactly.

When alcohol binds to these, it enhances the serotonin -mediated release of dopamine.

Ah, dopamine.

The major transmitter of the reward system.

You got it.

That massive dopamine release is what cements the behavior and really drives that compulsion to drink.

I always picture this like someone driving a car.

Alcohol simultaneously slams on the brakes.

That's the GABA enhancement.

Great analogy.

It reaches under the dash and cuts the accelerator wire that's blocking the excitatory glutamate.

And while the car is stalling out in the middle of the road, it just turns the radio all the way up, which is that dopamine release, making the whole thing feel incredibly rewarding.

That's exactly what's happening.

And the clinical reality of that stalled car is strictly dose -dependent.

How so?

Well, at low doses, alcohol primarily affects the higher brain centers, like the cortical areas.

This alters thought processes, learned behaviors, and releases inhibitions.

Which is why motor function and judgment are impaired first.

Right.

But as the dose increases, the depression moves deeper into the more primitive areas of the brain, specifically the medulla.

So reflexes diminish, consciousness is impaired.

And at very high doses, alcohol actually produces a state of general anesthesia.

Though obviously you'd never use it for clinical anesthesia.

No, never.

Because the anesthetic dose is dangerously close to the lethal dose.

Right.

But what about the long -term brain changes?

Because a patient with chronic AUD isn't just experiencing acute intoxication.

No, their actual brain structure and chemistry are changing over time.

Let's get into that.

What's driving those changes?

Chronic heavy drinking leads to severe neurologic and psychiatric disorders.

And a lot of that is heavily driven by nutritional deficiencies.

The major culprit being thiamine deficiency, right?

Exactly.

Chronic alcohol use physically suppresses the GI tract's ability to absorb thiamine.

And heavy drinkers typically have incredibly poor diets to begin with.

Which leads to those two common neuropsychiatric syndromes we see on exams and in the clinic.

Wernicke encephalopathy and Korsakoff psychosis.

Let's differentiate those because they present very differently.

Yeah, Wernicke encephalopathy shows up as confusion, nystagmus, and abnormal ocular movements.

And the critical takeaway for you as a clinician is that Wernicke is readily reversible.

If you act fast.

Right.

If you administer intravenous thiamine quickly, you can reverse it.

Yeah.

But Korsakoff psychosis is much more insidious.

That's the one with polyneuropathy, right?

Yeah.

Polyneuropathy, a profound inability to form new long -term memories and confabulation.

Confabulation is wild to see in practice.

The patient has these massive gaps in their memory and their brain just unconsciously fills those gaps with fabricated facts.

Yeah, they aren't intentionally lying to you.

Their brain is just desperately trying to make sense of the void.

And crucially, Korsakoff psychosis is not reversible.

So Korsakoff is permanent damage.

I mean, the brain is actually changing shape, isn't it?

Yes.

The data shows that long -term excessive consumption enlarges the cerebral ventricles.

Because the cerebrum itself is physically atrophying.

The actual brain matter is shrinking.

The structural damage is profound.

And even if the patient achieves long -term abstinence, those cognitive deficits often only partially reverse.

Now, I have to push back here for a second.

We constantly hear this pop culture medical advice that a little bit of alcohol, like a glass of wine a day, protects cognitive function and prevents dementia.

I hear that from patients all the time.

Are we saying that's completely false?

It's an essential distinction to make for your patients when they ask.

The isolated findings suggesting neuroprotection are specific to red wine only.

OK, so it's not the ethanol providing the benefit.

Not at all.

It is resveratrol, which is a natural antioxidant molecule found in the skin of red grapes.

Ethanol itself is purely neurotoxic.

That's a huge myth busted.

Here's another one.

Using alcohol as a sleep aid.

Oh, the classic nightcap.

Yeah.

Patients tell me all the time they have a drink to fall asleep.

It might help them lose consciousness faster, but it severely disrupts their sleep architecture.

How bad is the disruption?

It decreases total sleep time, it reduces the restorative quality of the sleep, and it depresses the airway muscles.

Oh, which intensifies snoring and drastically exacerbates obstructive sleep apnea.

Exactly.

It's terrible for sleep.

So if ethanol is causing that much structural and functional chaos in the central nervous system, what happens when it leaves the brain and hits the rest of the body?

Because it's absorbed right into the bloodstream, it impacts nearly every organ system.

We can group these effects by their underlying mechanisms.

Let's start with the cardiovascular system.

At moderate doses, alcohol causes vasodilation of cutaneous blood vessels.

So the patient's skin flushes and they feel warm.

Right, but that vasodilation means they're rapidly losing core body heat to the environment.

But chronically, it does the exact opposite in other parts of the body, doesn't it?

Heavy drinking elevates blood pressure.

Yeah, it triggers increased sympathetic nervous system activity.

This causes vasoconstriction in the vascular beds of skeletal muscle.

So the heart is pumping against increased resistance.

Add in the direct toxic damage to the myocardium over years of heavy use, and you're looking at a major cause of heart failure and cardiobiopathy.

Wow.

And you also need to be prepared to refute the idea of cardioprotection.

Definitely.

Prior observational research suggested moderate drinking reduced the risk of ischemic stroke and coronary artery disease.

But recent data has overturned that, right?

Completely.

Robust recent data shows that no amount of drinking provides cardioprotection.

In fact, it increases the risk for these diseases, particularly in biological females,

and scales up as consumption increases.

Right.

Now, speaking of surprising data, I was looking at the metabolic effects and wait, does alcohol actually lower the risk of type 2 diabetes?

It sounds like a headline waiting to be misinterpreted.

It is a really complex metabolic interaction.

Alcohol raises levels of adiponectin, which is a hormone that enhances cellular insulin sensitivity.

And it suppresses gluconeogenesis in the liver.

So physiologically, moderate use might decrease diabetes risk.

However, you would never, ever prescribe alcohol for this.

Because the systemic risks far outweigh that single metabolic shift.

Especially considering what it does to the liver.

Let's trace that pathway because it's a very specific decline.

The liver takes the brunt of the toxicity, right?

Starting with fatty liver.

Fatty liver is the early accumulation of triglycerides, and it is entirely reversible if the patient stops drinking.

But if they don't stop?

If they continue, about 90 % of heavy users progress to non -viral hepatitis, which is inflammation of the liver.

And the final stage?

The final stage is fatal cirrhosis, which occurs in up to 20 % of chronic patients.

Cirrhosis is irreversible structural damage.

The liver's functional parenchymal cells are destroyed and replaced by useless, rigid fibrous tissue.

The liver essentially turns into scar tissue.

The GI tract takes a massive hit too.

Ethanol acts as a direct solvent.

Yeah, it stimulates the overproduction of gastric acid while simultaneously eroding the protective mucosal lining of the stomach.

That's why a third of AUD patients develop erosive gastritis.

It can also trigger acute pancreatitis.

And what about the endocrine and renal systems?

Alcohol famously makes you have to pee.

It does.

It acts as a diuretic by directly inhibiting the release of antidiuretic hormone, or ADH, from the pituitary gland.

So without ADH telling the kidneys to retain water, they just flush fluid out, leading to dehydration.

That endocrine disruption also affects sexual function.

People think alcohol lowers inhibitions and acts as an aphrodisiac.

But objective measurements show it significantly decreases physiologic sexual responsiveness.

And in males, chronic use disrupts hormone metabolism in the liver.

Which can induce feminization causing testicular atrophy, impotence, and breast enlargement.

You also must communicate the cancer risk clearly to your patients.

Alcohol increases the risk for breast, liver, rectum, and air digestive tract cancers.

The consensus is clear.

Regarding cancer, no amount of alcohol is safe.

Any minor longevity games someone might argue for are mathematically erased by these heavy oncological risks.

Heavy drinkers have a much higher all -cause mortality rate.

Which makes the discussion around pregnancy even more critical.

Ethanol passes freely to a developing fetus.

Leading to fetal alcohol spectrum disorder, or FASD.

And the most severe form is fetal alcohol syndrome, right?

Characterized by craniofacial malformations, microcephaly, and profound neurodevelopmental abnormalities.

But occasionally you'll see a patient point to an older study.

Like those ones from 2010 suggesting light drinking might carry little risk.

What is the actual clinical guidance?

You adhere to the guidelines from the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics.

They maintain that no amount of alcohol is safe during pregnancy.

So you advise complete abstinence.

Complete abstinence.

That said, clinical tact is required.

Right.

Like if a patient consumed a small amount of alcohol before realizing she was pregnant?

Exactly.

You should reassure her that the absolute risk to the fetus from that early isolated exposure is extremely low just to prevent unnecessary panic.

What about postpartum?

You advise postpartum patients that alcohol easily enters breast milk, reaching concentrations parallel to the mother's blood.

This severely impairs infant feeding and behavior.

Okay, so why do some people handle this multi -system assault so differently?

Why does a couple of drinks affect a 140 -pound woman so differently than a 140 -pound man?

It all comes down to pharmacokinetics.

Let's get into that.

Because alcohol is a non -ionic, water -soluble molecule.

It distributes perfectly into all body tissues and fluids.

It crosses the blood -brain barrier and the placenta instantly.

And the gender difference in sensitivity?

That comes down to volume of distribution.

Women generally have a lower percentage of total body water than men of the exact same weight.

Right, so if a woman drinks a beer, that ethanol is diluted into a smaller volume of total water.

Meaning the concentration in her blood and tissues is immediately higher.

Plus, biological females generally have lower activity of the enzyme alcohol dehydrogenase in their stomach lining.

Exactly.

Less alcohol is neutralized in the stomach, so a larger percentage makes it into the bloodstream to begin with.

Once it is in the bloodstream, the liver has to clear it.

And this is where alcohol breaks the normal rules of pharmacology, doesn't it?

Yes, it follows zero -order kinetics.

This is a massive concept.

With most drugs, the more drug you have in your blood, the faster your body works to clear it.

The system scales up.

Right.

I like the toll booth analogy.

A normal drug is like a massive highway plaza.

If traffic backs up, they just open more lanes.

But alcohol metabolism is a single -lane toll booth on a dirt road.

No matter how much traffic or alcohol backs up, only one car gets through at a time.

The liver uses alcohol dehydrogenase to convert ethanol into acetaldehyde, and then a second enzyme turns it into acetic acid.

And that enzymatic process runs at an absolute fixed maximum speed.

It clears about 15 milliliters, or half an ounce, of pure alcohol per hour.

That was exactly one standard drink per hour.

So if a patient drinks faster than that, the toll booth is overwhelmed, the alcohol backs up in the bloodstream, and their blood alcohol concentration spikes.

And if they do this chronically for years, the liver tries to adapt.

It induces hepatic drug metabolizing enzymes, which slightly accelerates metabolism.

The brain also adapts, developing a massive tolerance to the subjective effects.

Yeah, they can function at blood alcohol levels that would render a naive drinker unconscious.

This cross -tolerance extends to general anesthetics and barbiturates, too, right?

It does.

Curiously, though, no cross -tolerance develops to opioids.

But here is the most terrifying part of that tolerance.

The real tightrope.

They build tolerance to the intoxicating effects.

But almost zero tolerance develops to the respiratory depression.

That is the danger zone.

So a severe AUD patient might be awake and talking to you with a blood alcohol level of 0 .4%.

But the lethal dose, the exact point where the brainstem forgets to tell the lungs to breathe,

barely changes.

The gap between feeling okay and respiratory arrest becomes incredibly narrow.

Which makes drug interactions exceptionally perilous.

Let's run through the big ones, NSAIDs.

If they take NSAIDs, the combined gastric irritation causes significant GI bleeding.

Acetaminophen.

The induced hepatic enzymes turn the Tylenol into a toxic metabolite, creating a massive risk for fatal liver injury.

And antihypertensives.

Because alcohol raises blood pressure through muscle vasoconstriction, it actively counteracts any antihypertensive medications you prescribe.

Man, and if that tightrope snaps and a patient overdoses, the presentation is classic CNS depression.

Vomiting, coma,

pronounced hypotension, and respiratory depression.

You have to verify this with blood, urine, or air tests.

Right, because smelling the breath is completely unreliable.

You aren't smelling ethanol, you're smelling the flavoring and impurities of the beverage.

Exactly.

Treatment for overdose is supportive gastric lavage, dialysis, managing the airway.

But remember the pathophysiology.

The hypotension is caused by direct vasodilation of peripheral blood vessels.

So using a vasoconstrictor like epinephrine will not fix it.

And you never, ever try to wake them up with stimulants like caffeine.

Never.

It only increases the cardiac burden.

Okay, so we know how it works, how it breaks down the body, and how people overdose.

But since a highly tolerant patient can walk into a clinic with a .3 % BAC and look completely fine, how do we actually spot them?

We define alcohol use disorder clinically as a chronic relapsing brain disease.

Characterized by impaired control over drinking.

Right.

Yes, impaired control, a deep preoccupation with alcohol, and continued use despite severe adverse physical or social consequences.

The NIAC provides a clinical framework.

Ask, assess, advise, assist, and continue support.

And to run the assessment, the gold standard is the IUD tool,

the alcohol use disorders identification test.

It's a 10 -question screening that goes beyond just asking how much do you drink.

You are scoring the frequency of drinking, typical volume, and binge frequency.

But more importantly, you score behavioral indicators,

like their inability to stop once they start, failing role obligations, needing a morning drink as an eye -opener, and feelings of guilt.

It's incredibly practical.

Each question scores from 0 to 4, making the max score 40.

For adult men up to age 60, a score of 8 or more flags a positive risk.

But because of the pharmacokinetic differences in body water metabolism we discussed earlier, the positive cutoff for women, adolescents, and older adults drops down to a score of 4.

Okay, so we've spotted them.

They score 15, they are highly dependent, and they want to quit.

You cannot just tell them to go home and dump the bottles down the drain.

No, absolutely not.

Abrupt cessation in a dependent patient triggers a severe abstinence syndrome.

Which carries a very real risk of death from seizures or cardiovascular collapse.

The first therapeutic goal is safe withdrawal.

We need pharmacological training wheels.

The clinical guidelines establish a clear gold standard for acute withdrawal, benzodiazepines.

Drugs like chlorazepoxide, chloropate, diazepam, and lorazepam.

Why benzose specifically?

Because they hit that same GABA receptor system that the alcohol just vacated.

Oh, that makes perfect sense.

Benzodiazepines stabilize the patient's vital signs, drastically reduce the intensity of withdrawal symptoms, and most importantly, prevent life -threatening complications like seizures and delirium tremens.

Clinically, agents with longer half -lives are preferred, right?

Yes, because they provide a smooth, sustained protection against breakthrough symptoms.

And interestingly, a PRN, or as -needed dosing schedule, based strictly on the patient's real -time symptom severity, is often much more effective than a rigid, around -the -clock, fixed schedule.

Definitely.

Now, you might see other medications on their chart during detox.

Like carbamazepine to help prevent seizures, or clonidine and beta blockers like Atenolol.

Right, to quiet down the autonomic nervous system and lower the heart rate.

But just to be crystal clear, these are adjuncts only.

They treat symptoms.

They are never substitutes for benzodiazepines.

Exactly.

They improve the comfort of the withdrawal, but they are not effective as monotherapy to prevent delirium tremens.

Okay, so detox usually takes a few days.

They survive it.

But detox is just the beginning.

Now that the therapeutic goal shifts entirely, we are playing the long game, maintaining abstinence or at least minimizing consumption.

We have three main pharmacological tools for this, and you have to match the drug's mechanism to the patient's specific psychological profile.

Let's start with Naltrexone.

I call this one the blocker.

Good name for it.

Naltrexone is a pure opioid antagonist.

It blocks the reinforcing pleasurable effects of alcohol and actively decreases craving.

The exact mechanism isn't perfectly understood, but it is likely that blocking the opioid receptors downstream prevents that massive dopamine release we talked about earlier.

Yeah, patients taking Naltrexone literally report that alcohol no longer gives them a high.

But I was looking at the clinical trial data on Naltrexone, and honestly, it's confusing.

How so?

The original trial showed it cut relapse rates by 50 percent, incredible results.

But then a massive VA study came out showing it failed entirely.

It was no better than placebo.

Which is it?

It comes down to psychosocial context.

The patients in the original successful trials had robust social support systems, intact families, and received extensive counseling alongside the medication.

And the VA study?

The VA study focused on severe, long -term, chronic patients who often lacked housing, had no social support, and received minimal behavioral therapy.

Ah, so the clinical takeaway is paramount.

Naltrexone requires a comprehensive management program.

A pill alone will not rewire a complex addiction.

When indicated, the dosing is 50 milligrams orally every day, or a 380 -milligram intramuscular depo injection once a month for adherence.

Got it.

Our second tool is acamprosate, which I think of as the balancer.

If Naltrexone blocks the high of drinking, acamprosate reduces the absolute misery of not drinking.

It reduces the tension, the dysphoria, the anxiety of protracted abstinence.

It does this by physically restoring the chemical balance between inhibitory GABA and excitatory glutamate that chronic alcohol destroyed.

It's ideal for patients with severe physical dependence, typically dosed at 666 milligrams orally three times a day.

But again, completely useless without psychosocial support.

Right.

And finally, we have our third option, disulfiram.

The punisher.

Yeah, this uses a completely different psychological mechanism.

Naltrexone uses blockade, acamprosate uses balance, disulfiram uses sheer terror.

It's pure aversion therapy.

The pharmacodynamics here are severe.

Break it down for us.

The disulfiram causes irreversible inhibition of the enzyme aldehyde adetalgenase.

Remember our single -lane toll booth?

Yeah, the liver processing the alcohol.

The disulfiram permanently barricades the exit lane.

The liver converts ethanol into highly toxic acetaldehyde, but it cannot convert it further into safe acetic acid.

So if a patient consumes even a drop of alcohol, that toxic acetaldehyde rapidly accumulates in the blood.

Triggering what we call the acetaldehyde syndrome.

And this syndrome is no joke.

The mild form is nausea, copious vomiting, flushing, and severe hypotension.

The severe form is cardiovascular collapse, respiratory depression, acute congestive heart failure, and death.

Wow.

And it can be brought on by as little as 7 milliliters of alcohol.

Because of this severity, disulfiram carries a black box warning.

It must never be administered to a patient who is currently intoxicated or who has consumed alcohol recently.

As a prescriber, your patient education must be flawlessly thorough.

They have to avoid all hidden sources of alcohol.

That means reading labels on vinegars, sauces, cough syrups, even topical applications like aftershaves and colognes can trigger a reaction.

And they need to understand the timeline.

Because disulfiram is an irreversible inhibitor, the body has to synthesize entirely new enzymes to clear it.

Right.

That means the threat of the acetaldehyde syndrome can last up to two full weeks after they take their very last dose.

Two weeks.

The initial dose is 500 milligrams daily for a week or two.

Then a maintenance dose of 125 to 500 milligrams.

Patient selection is absolutely everything here.

If they lack the determination to stop or if they have cognitive impairments that prevent them from understanding the risk,

you do not prescribe disulfiram.

It perfectly illustrates the delicate high stakes balance of clinical pharmacology.

It really does.

We're looking at how a single deceptively simple molecule like ethanol can hijack the body's fundamental neurotransmitters to such a profound systemic extent.

To the point that we are forced to deploy powerful opioid antagonists or severe life -threatening aversion therapies just to help the brain relearn how to exist without it.

It brings us right back to that master key kicking down the door.

It flips every switch in the house.

It takes an incredible amount of clinical reasoning, psychosocial support, and targeted pharmacology to turn them all back off.

Thank you for joining us for this deep dive.

It's been great.

From all of us on the Last Minute Lecture team, thank you for your time and we hope you take this knowledge straight into your clinical practice.

You've got this.